DENGUE FEVER

This study tests a dengue vaccine in adults aged 45 to 79, including those with conditions like diabetes or high blood pressure. Participants receive two shots three months apart. The goal is to check safety and how well the vaccine triggers an immune response against all four de…

This study follows 100 people with confirmed dengue fever to figure out which symptoms and lab results predict the need for hospital care. Researchers will also track how often blood transfusions are given and what happens afterward. The goal is to help doctors make better decisi…

This study creates a registry of 100 people with inherited bleeding disorders (like hemophilia) who get dengue fever. Researchers will track how often severe bleeding occurs, what treatments are needed, and survival rates. The goal is to gather data to improve care for this vulne…

This study looks at how well the dengue vaccine works in real life for children and teens in Thailand, Indonesia, and Malaysia. Researchers will follow 70,000 participants for up to 3 years to see if those who got the vaccine are less likely to be hospitalized with dengue. The go…